<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00629603</url>
  </required_header>
  <id_info>
    <org_study_id>KMUH-IRB-950347</org_study_id>
    <nct_id>NCT00629603</nct_id>
  </id_info>
  <brief_title>Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease</brief_title>
  <official_title>Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hepatitis C virus (HCV) infection causes different disease spectrum ranging from minimal
      progressive liver disease to cirrhosis or hepatocellular carcinoma. Evidence indicates that
      host genetic factor may play a role in determining disease progression. It is known that many
      cytokine polymorphisms affect disease progressin via increasing hepatic fibrosis that are key
      factors in progressing liver injury. By combinations of fibrosis-relating gene polymorphisms,
      this study aims to identify patients with high risk for progressive liver disease. These
      patients need intensive therapy to decrease morbidity and mortality of chronic HCV-related
      liver disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determination of the following fibrosis-relating gene polymorphisms in HCV-related chronic
      liver disease and HCC will be performed: TNF-α , TNF-β, Factor V Leiden, TGF-β1, PDGF-B gene,
      Angiotensinogen (AT),Angiotensin converting enzyme (ACE), microsomal epoxide hydrolase (mEH)
      and glutathione-S-transferase (GST).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cytokine gene polymorphism on disease severity</measure>
    <time_frame>years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">600</enrollment>
  <condition>Fibrosis</condition>
  <condition>Chronic Liver Disease</condition>
  <arm_group>
    <arm_group_label>cytokine polymorphisms, HCV infection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Relate the fibrosis cytokine gene polymorphisms with disease severity of HCV-related chronic liver disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>cytokine</intervention_name>
    <description>polymorphisms of fibrosis-relating cytokine were measured to validate the effectiveness of fibrosis in HCV-related chronic liver disease</description>
    <arm_group_label>cytokine polymorphisms, HCV infection</arm_group_label>
    <other_name>hepatitis C virus infection</other_name>
    <other_name>cytokine polymorphism</other_name>
    <other_name>fibrosis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>cytokine polymorphisms</intervention_name>
    <description>Fibrosis-relating cytokine polymorphisms in hepatitis C virus-related chronic liver disease were measured to validate the degree of fibrosis</description>
    <arm_group_label>cytokine polymorphisms, HCV infection</arm_group_label>
    <other_name>hepatitis C virus infection</other_name>
    <other_name>cytokine polymorphism</other_name>
    <other_name>fibrosis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>cytokine polymorphism</intervention_name>
    <description>fibrosis-relating cytokine polymorphism</description>
    <arm_group_label>cytokine polymorphisms, HCV infection</arm_group_label>
    <other_name>hepatitis C virus infection</other_name>
    <other_name>cytoline polymorphism</other_name>
    <other_name>fibrosis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with anti-HCV positive

        Exclusion Criteria:

          -  Anti-HCV-negative patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jung-Fa Tsai, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2008</study_first_submitted>
  <study_first_submitted_qc>March 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2008</study_first_posted>
  <last_update_submitted>April 17, 2013</last_update_submitted>
  <last_update_submitted_qc>April 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaohsiung Medical University Chung-Ho Memorial Hospital</investigator_affiliation>
    <investigator_full_name>Jung-Fa,Tsai (1)</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>hepatitis C virus infection</keyword>
  <keyword>chronic liver disease</keyword>
  <keyword>fibrosis-related cytokine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

